Stock KPTI KARYOPHARM THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Karyopharm Therapeutics Inc.

Equities

KPTI

US48576U1060

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
1.09 USD 0.00% Intraday chart for Karyopharm Therapeutics Inc. -21.01% +26.01%
Apr. 24 Karyopharm Therapeutics Inc. Announces Presentations in Endometrial Cancer and Myelofibrosis At the 2024 American Society of Clinical Oncology Annual Meeting CI
Mar. 13 Transcript : Karyopharm Therapeutics Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09:00 AM

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Karyopharm Therapeutics Inc. Announces Presentations in Endometrial Cancer and Myelofibrosis At the 2024 American Society of Clinical Oncology Annual Meeting
CI
Karyopharm Therapeutics : April 19, 2024
PU
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
Transcript : Karyopharm Therapeutics Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09:00 AM
Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences
PR
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
Karyopharm Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
AQ
Transcript : Karyopharm Therapeutics Inc., Q4 2023 Earnings Call, Feb 29, 2024
Karyopharm Therapeutics: Q4 Earnings Snapshot
AQ
Karyopharm Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Posts Q4 Revenue $33.7M, vs. Street Est of $33.6M
MT
Karyopharm Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Karyopharm Therapeutics Inc. Provides Earnings Guidance for the Year 2024
CI
North American Morning Briefing : Fed's Preferred -2-
DJ
Karyopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
PR
North American Morning Briefing : Stock Futures -2-
DJ
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
Transcript : Karyopharm Therapeutics Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 02:15 PM
Karyopharm Therapeutics Inc. Provides Preliminary Unaudited Earnings Guidance for the Fourth Quarter and Full Year 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KPTI Stock
  4. News Karyopharm Therapeutics Inc.